Patient demographics and baseline characteristics
| Variable . | All patients (n = 1175) . | CR (n = 195) . | VGPR (n = 212) . | PR (n = 397) . |
|---|---|---|---|---|
| Sex | ||||
| Male | 613 (52) | 89 (46) | 105 (50) | 217 (55) |
| Age, y | ||||
| Median | 72 | 71 | 71 | 72 |
| Range | 54-89 | 54-86 | 61-85 | 56-87 |
| > 75 | 314 (27) | 40 (21) | 44 (21) | 117 (29) |
| ISS stage* | ||||
| I | 223 (25) | 43 (28) | 39 (24) | 90 (29) |
| II | 430 (48) | 74 (47) | 79 (49) | 149 (47) |
| III | 241 (27) | 39 (25) | 43 (27) | 75 (24) |
| Missing | 281 | — | — | — |
| Durie and Salmon Staging System stage* | ||||
| II | 298 (32) | 34 (30) | 41 (26) | 113 (35) |
| III | 622 (68) | 78 (70) | 117 (74) | 206 (65) |
| Missing | 255 | — | — | — |
| Creatinine* | ||||
| > 1.2 mg/dL | 353 (30) | 48 (25) | 71 (33) | 110 (28) |
| Missing | 3 | — | — | — |
| Therapy | ||||
| MP | 332 (28) | 9 (5) | 27 (13) | 117 (29) |
| MPT | 332 (28) | 30 (15) | 67 (32) | 127 (32) |
| VMP | 257 (22) | 61 (31) | 65 (31) | 79 (20) |
| VMPT-VT | 254 (22) | 95 (49) | 53 (25) | 74 (19) |
| Variable . | All patients (n = 1175) . | CR (n = 195) . | VGPR (n = 212) . | PR (n = 397) . |
|---|---|---|---|---|
| Sex | ||||
| Male | 613 (52) | 89 (46) | 105 (50) | 217 (55) |
| Age, y | ||||
| Median | 72 | 71 | 71 | 72 |
| Range | 54-89 | 54-86 | 61-85 | 56-87 |
| > 75 | 314 (27) | 40 (21) | 44 (21) | 117 (29) |
| ISS stage* | ||||
| I | 223 (25) | 43 (28) | 39 (24) | 90 (29) |
| II | 430 (48) | 74 (47) | 79 (49) | 149 (47) |
| III | 241 (27) | 39 (25) | 43 (27) | 75 (24) |
| Missing | 281 | — | — | — |
| Durie and Salmon Staging System stage* | ||||
| II | 298 (32) | 34 (30) | 41 (26) | 113 (35) |
| III | 622 (68) | 78 (70) | 117 (74) | 206 (65) |
| Missing | 255 | — | — | — |
| Creatinine* | ||||
| > 1.2 mg/dL | 353 (30) | 48 (25) | 71 (33) | 110 (28) |
| Missing | 3 | — | — | — |
| Therapy | ||||
| MP | 332 (28) | 9 (5) | 27 (13) | 117 (29) |
| MPT | 332 (28) | 30 (15) | 67 (32) | 127 (32) |
| VMP | 257 (22) | 61 (31) | 65 (31) | 79 (20) |
| VMPT-VT | 254 (22) | 95 (49) | 53 (25) | 74 (19) |
Data are number and (%).
— indicates not applicable.
Percentage was calculated based on the number of patients whose data were available.